Prelude Therapeutics
Murty Mangena has a diverse work experience in technical operations, CMC (chemistry, manufacturing, and controls), regulatory affairs, and pharmaceutical research and development. They have held executive and management positions in various companies such as Prelude Therapeutics Incorporated, Deciphera Pharmaceuticals, Parnell Veterinary Pharmaceuticals, Argenta Limited, and Aptuit (Catalent). Additionally, they have worked as an independent consultant and have experience in bio pharmaceutical development. Mangena has also worked as a research associate at the University of Kentucky.
Murty Mangena has a background in Chemistry and Microbiology, obtaining a Ph.D. from the Indian Institute of Technology, Madras. Later, Murty pursued further education as a Postdoctoral Fellow at the University of Kentucky, focusing on the field of Bio-chemical Processing of Hydrocarbons.
This person is not in any offices
Prelude Therapeutics
3 followers
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways.